Management of primary angle closure glaucoma with cataract extraction
Abstract
Background: We investigate the clinical result of phacoemulsification with foldable posterior chamber intraocular lens (PC-IOL) implantation in the management of primary angle closure glaucoma with cataract.
Methods: We performed phacoemulsification with foldable PC-IOL implantation in the eyes with primary angle closure glaucoma and cataract. Eyes were divided in three groups. In the first group were eyes with primary acute-closed angle glaucoma with no PAS (peripheral anterior synechiae). In the second group were eyes with primary chronic angle-closure glaucoma with less than 180° of PAS. In the third group were eyes with primary chronic angle-closure glaucoma with more than 180° of PAS seen on gonioscopic examination.
Results: In the first group of 15 patient mean follow up time was 10.7 month. IOP change from mean 58 mmHg to mean 13.5 mmHg postoperative. ACD change from 2.31 mm to 3.67 mm postoperative. Best corrected visual acuity change from 0.25 to 0.7 postoperative. In the second group of 30 patient mean follow up time was 15.9 months. IOP fall from mean 19.9 mmHg to mean 12.1 mmHg postoperative. ACD change from 2.45 mm to 3.93 mm postoperative. Best corrected visual acuity change from 0.4 to 0.83 postoperative. In the third group of 15 patient mean follow up time was 9.6 month. IOP fall from mean 16.4 mmHg to mean 14.5 mmHg postoperative. ACD change from 2.51 mm to 4.20 mm postoperative. Best corrected visual acuity change from 0.25 to 0.54 postoperative.
Conclusions: Phacoemulsification with PC-IOL implantation can be a good alternative in treating eyes with cataract and primary acute and chronic angle closure glaucoma with less than 180° of PAS seen on gonioscopic examination. With cataract surgery performing soon after diagnosing primary angle closure glaucoma we can prevent chronical disease. With this the patient quality of life is beater and with less therapy.
Downloads
References
European Glaucoma Society. 2003 Terminology and guidelines for glaucoma. Savona, Italy: Editrice Dogma, 2003.
The American Academy of Ophtalmology. Basic nad clinical science course. Glaucoma; 1996–1997; San Francisco, CA.
Lowe RF, Ritch R. Angle-closure glaucoma. Mechanisms and epidemology. In: Ritch R, Shields MB, Krupin T. The glaucomas. St. Louis: Mosby; 1996.
The American Academy of Ophtalmology. Preferred practice pattern. Primary angle-closure glaucoma, 1996.
Lowe RF, Ritch R. Angle-closure glaucoma. Mechanism and epidemiology. In: Ritch R, Shields MB, Krupin T. The glaucomas. St. Louis: Mosby; 1996. p. 801–20.
Cvenkel B. Smernice za zdravljenje glavkoma. Ljubljana: MSD; 2001.
Palmberg P. Gonioscopy. In: Ritch R, Shields MB, Krupin T eds. The glaucomas. St. Louis: Mosby; 1996. p. 455–69.
Traverso CE. Angle-closure glaucoma. In: Duker JS, Yanoff M eds. Opthalmology. St. Louis, Mosby 2002.
Hoskins H D Jr, Kass M. Becker-Shaffer’ diagnosis and therapy of the glaucomas. St. Louis: Mosby; 1989.
Zupan M, Schwarzbartl Pfeifer MA, Pfeifer V, Cvenkel B. Operacija sive mrene v terapiji primarnega glavkoma z zaprtim zakotjem. Abstract book. Slovenski oftalmološki kongres; 2002; Maribor, Slovenija.
The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 6. Effect of cataract on visual field and visual acuity. Arch Opthalmol 2000; 118: 1639–52.
Fran Fran Smith MA. Clinical examination of Glaucoma. In: Yanoff M, Dueker J eds. Opthalmology. London: Mosby; 1999. p. 12:4.1–4.3.
Alward WLM. Color atlas of gonioscopy. London: Mosby; 1994.
Riley SF, NAirn JP, Maestre FA, Smith TJ. Analysis of the anterior chamber angle by gonioscopy and by ultrasound biomicroscopy. Int Opthalmol Clin 1994; 34: 271–82.
Marchini G, Pagliarusco A, Toscano A, Tosi R, Brunelli C, Bonomi L. Ultrasound biomicroscopic and conventional ultrasonographic study of ocular dimensions in primary angle-closure glaucoma. Opthalmology 1998; 105: 2091–8.
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Konaroff E, for the Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment. Arch Opthalmol 2003; 121: 48–56.
Martin XD. Normal intraocular pressure in man. Opthalmologica 1992; 205: 57–63.
Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M, for the Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression. Results From the Early Manifest Glaucoma Trial. Arch Opthalmol 2002; 120: 1268–79.
Fellman, Ronald MD. Changes in anterior chamber angle width and depth after IOL implantation in eyes with glaucoma. Evidence-Based Eye Care 2001; 2(1): 52–5.
Jacobi PC, Dietlein TS, Luke C et al. Primary phacoemulsification and intraocular lens implantation for acute angle-closure glaucoma. Ophthalmology 2002; 109: 1597–603.
Toshiaki Kubota, Ichiro Toguri, Naoko Onizuka, Toshie Matsuura. Phacoemulsification and intraocular lens implantation for angle closure glaucoma after the relief of pupillary block. Ophthalmologica 2003; 217: 325–8.
Aung T, Ang LP, Chan SP, Chew PTK. Acute primary angle-closure: longterm intraocular pressure outcome in Asian eyes. Am J Ophthalmol 2001; 131: 7–1.
Gunning FP, Greve EL. Lens extractionfor uncontrolled angle closure glavcoma: long term follow up. J Catarac Refract Surg 1998; 24(10): 1347–56.
Ho CL, Walton DS, Pasquale LR Lens extraction for angle closure glavkoma. Ophthalmol Clin 2004; 44(1): 213–28.
Congdon NG, Friedman DS. Angle-closure glaucoma: impact, etiology, diagnosis, and treatment. Current Opin Ophthalmol 2003; 14(2): 70–3.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
